Is my portfolio
One Report to Answer all your Questions!
Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
927.15
3.50 (0.38%) Natco Pharma informs about press release
Date: 15-12-2015Natco Pharma has informed about a Press Release dated December 15, 2015 titled ‘NATCO receives generic Ledipasvir + Sofosbuvir approval for India’.
The above information is a part of company’s filings submitted to BSE.